A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.

Spiders can be an uncomfortable presence for many people but thanks to a new development, their silk is set to enhance nerve ...

Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...

Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...

Glaukos has secured EU Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other MIGS ...

Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...

A professor from the University of Sheffield has received over £0.39m ($0.45m) in funding from Breast Cancer Now to develop a ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

Vivasure Medical has submitted an application seeking premarket approval from the FDA for its PerQseal Elite vascular closure ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Stryker’s Incompass Total Ankle System.

Experts at HLTH Europe discussed how to ensure patients have trust in the EHDS to ensure a successful roll-out.

ExoStat Medical has completed an intensive care unit (ICU) observational septic shock study of its MicroTREND System.